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Objectives 
Raised vascular function measures are associated with development of adverse maternal and 
perinatal outcomes in low risk pregnancy. This study aimed to evaluate the association 
between longitudinal vascular function parameters and adverse outcomes in pregnant women 
with chronic hypertension. 
Methods 
Pregnant women recruited to the PANDA (Pregnancy And chronic hypertension: NifeDipine vs 
lAbetalol as antihypertensive treatment) trial in three UK maternity units had serial pulse wave 
analyses performed using the Arteriograph® (Tensiomed, Budapest, Hungary) while in a sitting 
position from 12 weeks onwards. Statistical analysis used random-effects logistic regression 
models and compared those who developed superimposed pre-eclampsia (SPE) to those who 
did not, women who delivered a small for gestational age infant (<10th birthweight centile) 
(SGA10) to those who delivered an infant with birthweight >10th centile, and women of Black 
ethnicity with women of non-Black ethnicity.  
Results 
The cohort included 97 women (90% (n=87) randomised to antihypertensive treatment), with 
up to six longitudinal vascular function assessments (mean 3), (57% (n=55) of Black ethnicity) 
with chronic hypertension and singleton pregnancies. SPE was diagnosed in 18% (n=17) and 
30% (n=29) of infants were SGA10. In women who developed subsequent SPE compared to 
those who did not, mean brachial systolic blood pressure (SBP) (148 vs 139 mmHg; p=0.002), 
mean diastolic blood pressure (DBP) (87 vs 82 mmHg; p=0.01), mean central aortic pressure 
(139 vs 128 mmHg; p=0.001) and mean augmentation index (AIX-75) (29 vs 22%; p=0.01) were 
significantly higher across gestation. Mean brachial SBP (146 vs 138 mmHg; p=0.001), mean 
DBP (86 vs 82 mmHg; p=0.01), mean central aortic pressure (137 vs 127 mmHg; p=<0.0001), 
and mean PWV (9.1 vs 8.5 m/s; p=0.02) were higher across gestation in women who delivered 
an SGA10 infant compared to women who delivered an infant with birthweight >10th centile. 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
No longitudinal differences were found in the vascular function parameters in women of Black 
ethnicity compared to non-Black ethnicity.  
Conclusion 
There are persistent differences in vascular function parameters and brachial blood pressure 
through pregnancy in women with chronic hypertension who later develop adverse maternal 
and perinatal outcome. Further investigation of the possible clinical use of these findings is 
warranted. 
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INTRODUCTION 
Chronic hypertension complicates 3% of pregnancies.(1, 2) The risk of adverse maternal and 
perinatal outcomes in women with chronic hypertension, such as SPE(3-5) and fetal growth 
restriction(3, 6), are dramatically increased compared to the general pregnant population. The 
increased maternal vascular resistance and decreased vascular compliance associated with 
chronic hypertension may cause maladaptation to the physiological demands of pregnancy.(7, 
8) However the mechanisms underpinning these differences in pregnancy outcome in women 
with chronic hypertension are poorly understood.  
 
Pulse wave analysis is a non-invasive technique that utilises the peripheral pressure 
waveforms, and generation of the corresponding central waveform, to derive vascular function 
measures of pulse wave velocity (PWV), augmentation and aortic (‘central’) pressure. These 
parameters all have prognostic value because, in the non-pregnant population, they predict 
increased risk of cardiovascular disease.(9-11) There is also evidence that these measures may 
change in pregnancy prior to development of pre-eclampsia.(12, 13) Increased brachial blood 
pressure is associated with subsequent adverse perinatal outcome. Previous studies have 
demonstrated an association between the diagnosis of pre-eclampsia and subsequent 
increased risk of cardiovascular morbidity and mortality.(14, 15) Investigation of arterial 
stiffness parameters in women with chronic hypertension in pregnancy may offer some insight 
into the mechanism behind this increased risk.  
 
An association between Black ethnicity and adverse pregnancy outcome has been 
demonstrated.(16-19) Prevalence of chronic hypertension is higher at a younger age among 
Black women, compared to White,(20, 21) and Black ethnicity, compared to White, is 
associated with an increased lifetime risk of cardiovascular morbidity and mortality.(22, 23) A 
sub-analysis of the women with chronic hypertension who participated in the Vitamin In 
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Pregnancy trial demonstrated an association between Black ethnicity (compared to White) and 
SPE.(5) Exploration of the impact of ethnicity on pulse wave analyses in pregnancy complicated 
by chronic hypertension may provide insight into pathophysiological mechanisms 
underpinning ethnic differences in pregnancy outcome. This study aimed to investigate 
longitudinal vascular function in women with chronic hypertension in pregnancy, using pulse 
wave analysis, to determine if there is variation in these measures in women with subsequent 
SPE, SGA10 and whether these vary by baseline parameters such as Black ethnicity. 
 
METHODS 
This was a nested cohort study of women with chronic hypertension who participated in the 
PANDA (Pregnancy And chronic hypertension: NifeDipine vs lAbetalol as antihypertensive 
treatment) study between 2014 and 2016. The PANDA study was primarily a randomised 
controlled feasibility study comparing labetalol and nifedipine for control of chronic 
hypertension in pregnancy (demonstrating comparable effectiveness of both agents at 
controlling blood pressure to treatment target across gestation within the limitations of small 
numbers for this clinical endpoint). Women within the PANDA study together with those who 
were ineligible for randomisation (due to medication contraindication) or who declined 
randomisation (but met eligibility criteria) were invited to participate in this observational arm 
of the study. The study was registered with ISRCTN (DOI 10.1186/ISRCTN40973936, 
www.isrctn.com) and approved by the UK Research Ethics Committee (REC number 
13/EE/0390). The study has been reported in line with STROBE guidance for reporting of 
cohort studies.(24)  
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Study Design 
Women were enrolled at three consultant-led National Health Service (NHS) obstetric units in 
the United Kingdom (Guy’s and St Thomas’ NHS Foundation Trust, Central Manchester 
University NHS Foundation Trust, and St George’s University Hospitals NHS Foundation Trust). 
The eligibility criteria included women with a prenatal diagnosis of chronic hypertension 
(requiring antihypertensive treatment) or blood pressure readings ≥140/90 mmHg prior to 20 
weeks’ gestation requiring antihypertensive treatment, as defined by the International Society 
for the Study of Hypertension in Pregnancy classification of hypertensive disorders of 
pregnancy,(25) between 12 and 27.9 weeks’ gestation, singleton pregnancies, aged over 18 
years, and with ability to provide informed consent. Longitudinal vascular function of the study 
participants was measured using pulse wave analysis. Baseline demographic and antenatal 
booking data were collected at enrolment. Ethnicity (Black vs non-Black) was determined by 
whether the woman had a parent or grandparent who was African or Caribbean by self-report. 
Clinical blood pressure readings taken at all subsequent antenatal visits (using automated and 
manual blood pressure devices) and daily during hospital admissions (highest of that day) were 
recorded in addition to other maternal and perinatal outcome data (SPE, mode of delivery, 
gestation at delivery, pregnancy loss, birthweight, birthweight centile and neonatal unit 
admission). SPE was defined as new-onset proteinuria, a sudden increase in proteinuria if 
already present in early gestation, and an increase in hypertension, as recommended by the 
American College of Obstetrics and Gynaecology practice bulletin.(26) Customised birthweight 
centiles were calculated using the GROW formula with adjustment for maternal height, 
maternal weight, maternal ethnicity, parity, infant sex, infant birthweight and gestation at 
birth (version 6.7.5.1 (2014)).(27) Infant birthweight below the 10th centile was considered 
diagnostic of small for gestational age (SGA10).  
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Pulse Wave Analysis 
Pulse wave analyses were obtained using the Arteriograph® (Tensiomed, Budapest, Hungary), 
an oscillometric single-cuff device. Readings were obtained at study enrolment, 20 weeks, 28 
weeks, and 34 weeks’ gestation (+/- two weeks). All pulse wave measurements were 
performed with participants in the sitting position. The Arteriograph® cuff was applied to the 
left arm over the brachial artery for estimation of central aortic pressure (mmHg), PWV (m/s) 
and AIX (%). The AIX was also converted to an additional vascular function parameter AIX-75, 
adjusting for a heart rate of 75 beats per minute using the formula AIX -(0.431 x (75-heart 
rate)), in view of the linear relationship between the AIX and heart rate. The device 
additionally recorded brachial SBP and DBP (mmHg). All recordings were made by researchers 
who had received appropriate training on the use of the Arteriograph®. The results of the pulse 
wave analyses were not given to the women or their doctors and did not influence the 
subsequent management of the pregnancies.   
 
Statistical Analysis 
The statistical software Stata version 14 (StataCorp, College Station, Texas) and GraphPad 
Prism 7 (Graph Pad Software, San Diego, California) were used for all analyses. The 
investigation concentrated comparison using three groupings of study women, all of whom 
had chronic hypertension.  Grouping A: women who developed SPE compared with women 
who did not develop SPE. Grouping B: women who gave birth to an SGA10 infant compared 
with women who gave birth to an infant with a birthweight >10th centile. Grouping C: Black 
women compared with non-Black women. Baseline characteristics, clinical outcomes and 
longitudinal vascular function parameters were compared using groupings A, B, and C. Clinical 
brachial blood pressure measurements were also compared for each grouping. 
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Baseline characteristics and clinical outcomes were compared between groupings using t-tests 
or Mann-Whitney test for continuous variables depending on the distributions and Fisher’s 
exact test or Chi-squared test for categorical variables. Following confirmation of Normal 
distribution, the mean and standard deviation (SD) of each vascular function measure within 
each comparison was calculated.  The adjusted mean difference (AMD) and associated 95% 
confidence interval (CI) for each vascular function parameter was assessed for each grouping 
(A, B and C) using mixed effects maximum likelihood regression models allowing for gestation 
effects, and repeated measures in the same woman across gestation. Descriptive analysis 
demonstrating the variation in each vascular function parameter over gestation was 
conducted by calculating mean and standard error of the readings taken within 4-weekly 
gestation intervals (12 to 15+6, 16 to 19+6, 20 to 23+6, 24 to 27+6, 28 to 31+6 and 32 to 35+6 
weeks) for each comparison adjusting for repeat readings in the same woman and displayed 
graphically.  
 
RESULTS 
The total number of women enrolled into this cohort study was 106 (Figure 1 details flow of 
study participants). Of these, four (3.8%) withdrew or were lost to follow-up, and five (4.7%) 
were excluded from this analysis as they had a second trimester pregnancy loss. Longitudinal 
vascular function assessments (290 in total) were obtained in 97 women (92%). Of the 290 
readings obtained, 16 (5.5%) did not provide an AIX or PWV value and eight (2.9%) of the 
readings with AIX and PWV could not be included in the analyses of these parameters, as the 
standard deviation of the pulse wave was greater than the pre-specified 1.5 cut-off. For 
analysis A the cohort was divided into women diagnosed with SPE (n=17) and compared with 
women who were not diagnosed with SPE (n=80), for analysis B women with infants born 
below the 10th birthweight centile (n=29; of which n=12 also had SPE (41%)) were compared 
with women with infants born above the 10th birthweight centile (n=68; of which n=5 had SPE 
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(7.4%)), and for analysis C the cohort was divided into women of Black ethnicity (n=55) versus 
women self-identifying as of non-Black ethnicity (n=42). The results are presented with 
summary tables for comparisons of the vascular function variables within each of the three 
analyses (Tables 4, 5 and 6), but the figures are collated by vascular function variable across 
the three analyses (A, B and C) to allow visual comparison of the longitudinal variation and 
inter-relationship between analyses (Figures 2 to 7).       
 
The baseline demographics of the cohort are detailed in Table 1 (and Supplementary Table S1). 
Body mass index was higher in the Black women compared to the non-Black women (32 kg/m2 
versus 29 kg/m2; p=0.02). There was a lower proportion of nulliparous women in those of Black 
ethnicity compared to non-Black ethnicity (3.6% versus 31%; p=<0.0001), and the median 
antenatal booking SBP was higher in the women of Black ethnicity compared to the women of 
non-Black ethnicity (140 mmHg versus 134 mmHg; p=0.02). Otherwise baseline characteristics 
were comparable between subgroups. 
 
Adverse maternal and perinatal outcomes were common in the cohort as a whole, with 18% 
(n=17) of women developing SPE in their pregnancy, 63% (n=61) of women requiring a 
Caesarean birth, 24% (n=23) of births occurring before 37 weeks’ gestation, and 3.1% (n=3) 
stillbirths. Other adverse neonatal outcomes included 30% (n=29) SGA10, 14% (n=14) of 
infants with birthweight <3rd centile, and 22% (n=21) of infants requiring admission to the 
neonatal unit. There were no significant differences in maternal and perinatal outcomes 
between the women of Black ethnicity and non-Black ethnicity (Table 2,3, Supplementary 
Table S2 and S3).  
 
The women who developed SPE had higher peak SBP and DBP (180 mmHg versus 160 mmHg; 
p=0.0003 and 107 versus 97 mmHg; p=0.004 respectively) and were more likely to require an 
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emergency Caesarean section for delivery (76% versus 39%; p=0.006) compared to those who 
did not. Women with SPE were delivered earlier (median 33 weeks’ gestation) compared to 
those without (median 39 weeks’ gestation; p=<0.0001) with lower birthweight babies (1560g 
vs. 3030g;) p=<0.0001) and with a greater proportion of infants who required admission to the 
neonatal unit (76% versus 10%; p=<0.0001). Similarly, amongst those who gave birth to an 
SGA10 infant, compared to those who gave birth to infants of birthweight >10th centile, the 
peak SBP and DBP were higher (175 mmHg versus 158 mmHg; p=0.001 and 100 mmHg versus 
97 mmHg; p=0.048). Infants with a birthweight below the 10th centile, compared to those 
above, were more likely to be born before 37 weeks’ gestation (52% versus 12%; p=<0.0001) 
and were more likely to require neonatal unit admission (48% versus 10%; p=<0.0001). 
 
Analysis A: Comparison of vascular function parameters between women with chronic 
hypertension who did and did not develop superimposed pre-eclampsia 
 A summary of the comparison of vascular function parameters in women who did and did not 
develop SPE is in Table 4. Across gestation the SBP and DBP measurements taken by the 
Arteriograph® were higher in the women whose pregnancies were complicated by SPE (148 
mmHg versus 139 mmHg; AMD 10 mmHg, 95% CI 4 to 16; p=0.002 and 87 mmHg versus 82 
mmHg; AMD 5 mmHg, 95% CI 1 to 9; p=0.01), as were the central aortic pressure and the AIX 
adjusted for a heart rate of 75 beats per minute (139 mmHg versus 128 mmHg; AMD 12 
mmHg, 95% CI 5 to 20; p=0.001 and 29% versus 22%; AMD 6 mmHg, 95% CI 1 to 11; p=0.01 
respectively).  
 
Analysis B: Comparison of vascular function parameters between women with chronic 
hypertension who delivered a small for gestational age infant (birthweight <10th centile) and 
those who delivered an infant with a birthweight ≥10th centile. 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
A summary of the comparison of vascular function parameters in women who gave birth to an 
SGA10 infant with those who gave birth to an infant with a birthweight above the 10th centile 
is presented in Table 5. Brachial SBP and DBP were significantly higher across gestation in the 
women who delivered an SGA10 infant (146 mmHg versus 138 mmHg; AMD 9 mmHg, 95% CI 4 
to 14; p=0.001 and 86 mmHg versus 82 mmHg; AMD 4 mmHg, 95% CI 1 to 8; p=0.01 
respectively). Mean central aortic pressure across gestation was 137 mmHg in women who 
gave birth to an SGA10 infant compared to 127 mmHg in women whose infant’s birthweight 
was ≥10th centile (AMD 11 mmHg, 95% CI 5 to 18; p=<0.0001). In addition, the mean PWV 
across gestation was 9.1 m/s in women who delivered an SGA10 infant compared to 8.5 m/s in 
those who did not (AMD 0.7 m/s, 95% CI 0.1 to 1.4, p=0.02).      
 
Analysis C: Comparison of vascular function parameters between women with chronic 
hypertension of Black ethnicity and non-Black ethnicity 
Table 6 summarises the vascular function comparisons made between women of Black and 
non-Black ethnicity with chronic hypertension in pregnancy. No significant differences in 
vascular function across gestation were found by ethnic group. 
 
Longitudinal variation in vascular function parameters across gestation  
The graphs in Figures 2 to 7 demonstrate the gestational variation in each vascular function 
parameter for each comparison (A, B and C). 
 
Comparison of clinical systolic and diastolic blood pressure readings for each comparison 
Given the relationship observed between brachial SBP and DBP and outcomes as measured 
using the Arteriograph®, further comparison was made repeating analysis A, B and C utilising 
the clinically recorded blood pressure measurements taken within the study. This analysis 
confirmed that there was a significant relationship between brachial blood pressure and 
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subsequent SPE with systolic blood pressure 11 mmHg higher across gestation (95% 
confidence interval 7 to 15 mmHg; p <0.0001) and diastolic blood pressure 5 mmHg higher 
across gestation (95% confidence interval 2 to 8 mmHg; p=0.003) in women who developed 
SPE compared to those who did not. Raised brachial blood pressure was also associated with 
subsequent SGA10 in women with chronic hypertension, with systolic blood pressure 9 mmHg 
higher (95% confidence interval 5 to 12 mmHg; p <0.0001) and diastolic blood pressure 4 
mmHg higher (95% confidence interval 1 to 6 mmHg; p 0.002) in women who gave birth to 
SGA10 infants compared to women who gave birth to infants who had a birthweight ≥10th 
centile. No relationship was demonstrated between clinical blood pressure and ethnicity. 
Figures 8 and 9 present the comparisons made of clinical systolic and diastolic blood pressure 
measurements across gestation respectively. 
 
DISCUSSION 
To our knowledge this is the first study to report longitudinal changes in pulse wave analyses 
using the Arteriograph® device exclusively in women with chronic hypertension in pregnancy. 
We demonstrated that longitudinally elevated brachial systolic and diastolic blood pressure 
predate the development of adverse pregnancy outcome (including SGA10) in women with 
chronic hypertension. These findings are in keeping with data from other studies 
demonstrating an association between clinically measured elevated blood pressure and 
adverse outcome, particularly for those with severe hypertension.(28) An increase in other 
vascular function parameters across gestation also pre-dates the development of SPE and 
SGA10 in this cohort. An association between increased central aortic pressure and 
subsequent diagnosis of pre-eclampsia has previously been demonstrated by Khalil and 
colleagues (2014) using this device in women who were normotensive at study enrolment.(29) 
Additionally, raised AIX and AIX-75 have been demonstrated in women with pre-eclampsia, 
both prior to and at the time of diagnosis.(29-33) Our study did not demonstrate an 
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association between unadjusted AIX and pregnancy outcome, but AIX-75 was increased across 
gestation in women who developed SPE, compared to those who did not.  
 
In a population screening study examining the utility of arterial stiffness assessment in 
predicting adverse pregnancy outcome (including 7500 women), 68 women had chronic 
hypertension including 21 who subsequently developed SPE and 47 who did not.(33) In those 
who developed SPE, compared to those who did not, the central aortic pressure was 
increased, but there was no significant difference in PWV or AIX-75.(33) A cross-sectional 
cohort study of 41 pregnant women with chronic hypertension, conducted by Tomimatsu and 
colleagues (2014), also demonstrated an association between increased AIX-75 and SPE.(12) 
This study found that increased brachial SBP and central aortic pressure pre-dated the 
development of SPE with SGA10 at 26 to 32 weeks’ gestation compared with women with 
chronic hypertension who had SPE alone, SGA10 alone, or no SPE/SGA10. The approach of 
subdividing their cohort reduced the power and may have affected the results. Given that our 
study was not aimed primarily at prediction, no comparison of SGA10 alone was made. 
 
The relationship between blood pressure and placental insufficiency is complex. There are 
many studies that demonstrate an increased incidence of fetal growth restriction associated 
with chronic hypertension in pregnancy, both in association with and independently of a 
diagnosis of SPE.(3-6) Previously fetal growth restriction has been linked to antihypertensive 
treatment in women with hypertensive disorders of pregnancy, with a hypothesis that the 
reduction in blood pressure caused by the antihypertensive agents also reduced placental 
blood flow, leading to fetal growth restriction.(34) However, the Control of Hypertension In 
Pregnancy Study (CHIPS, reported 2015) demonstrated that there was no significant adverse 
effect of tight blood pressure control (target DBP 80-85 mmHg), compared to less tight control 
(target DBP 100-105 mmHg), on the risk of SGA10 between intervention groups (16% versus 
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20%; odds ratio 0.78, 95% confidence interval 0.56 to 1.08).(35) The impact of 
antihypertensive treatment on the incidence of fetal growth restriction if a diastolic blood 
pressure target below 85 mmHg is utilised needs to be established, as the CHIPS protocol 
recommended cessation of antihypertensive treatment if diastolic was <80 mmHg. However, 
our study demonstrates an association between increased brachial SBP and DBP across 
gestation and subsequent delivery of an SGA10 infant in women with chronic hypertension in 
pregnancy. Though superimposed pre-eclampsia may explain some of this increased risk, the 
potential contribution of second trimester blood pressure to predict SGA10 warrants further 
investigation and could aid risk stratification of antenatal care pathways including increased 
ultrasound surveillance.  
 
No ethnic variation in vascular function parameters was demonstrated in this study. Khalil and 
colleagues (2009) also found no ethnic variation in vascular function parameters, but in 
normotensive pregnancy.(36) However, a study by Brewster and colleagues (2010) 
demonstrated increased resistance artery contractility in Black normotensive pregnant 
women, compared with White.(37) In order to confirm if ethnic variation in vascular function 
parameters exist and have a role in the pathophysiology underpinning the ethnic disparity in 
pregnancy outcome observed in previous cohort studies, a much larger study is needed. 
 
The strengths of this study include recruitment of women with chronic hypertension alone to 
allow investigation of vascular function differences in this group. The study was conducted at 
three centres, making the results more generalisable and including a wider UK cohort. 
Performing longitudinal pulse wave analyses allowed assessment of changes in vascular 
function parameters that occurred prior to clinical diagnosis of any adverse outcome. The 
limitations include the relatively small number of participants, though our study was larger 
than previous cross-sectional studies that examined vascular function in chronic hypertension 
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alone.(12) The potential clinical utility of these parameters in diagnosis of SPE could not be 
ascertained as no ‘time of disease’ readings were obtained, and 8.4% of readings did not 
record the AIX or PWV, suggesting further optimisation of this technique is required prior to 
establishing the use of this device in clinical practice. 
 
Future research needs to establish whether the measurement of vascular function parameters 
(PWV, AIX CAP) in pregnancy complicated by chronic hypertension offers benefit above the 
standard brachial blood pressure measurements used in current clinical practice. This is 
particularly pertinent given the association demonstrated within this study between increased 
clinical systolic and diastolic blood pressure and subsequent SPE and/or SGA10. Differing 
antihypertensive agent effects on vascular function parameters have been observed, in the 
absence of brachial blood pressure variation.(38) If such treatment differences were observed 
in a pregnant population, the assessment of vascular function may prove a useful adjunct to 
current clinical management of chronic hypertension in pregnancy. It would also be beneficial 
to establish if vascular function parameters measured in the first or second trimester could be 
used to predict SPE or SGA10. 
     
In conclusion, there are persistent differences in vascular function parameters and brachial 
blood pressure through pregnancy in women with chronic hypertension who later develop 
adverse maternal and perinatal outcome. Further investigation of the possible clinical use of 
these findings is warranted. 
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FIGURE CAPTIONS: 
Figure 1 Overview flow of study participants including grouping for analyses A, B and C 
CHT= chronic hypertension, SPE=superimposed pre-eclampsia, SGA10=neonates with 
birthweight below the 10th centile 
Participants of vascular function sub-study only presented in this schematic. The five second 
trimester losses included one fetal demise at 15 weeks’ gestation, one miscarriage secondary to 
premature rupture of membranes and subsequent induction for chorioamnionitis, one late 
miscarriage secondary to cervical incompetence, and two terminations for fetal indications.  
 
Figure 2 Brachial systolic blood pressure across gestation in pregnant women with chronic 
hypertension.  
Comparison A: SPE vs no SPE. Comparison B: SGA10 vs no SGA10. Comparison C: women of 
Black ethnicity vs women of non-Black ethnicity. The limits of the axes represent the maximum 
and minimum value within the dataset for each parameter. 
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Figure 3 Brachial diastolic blood pressure across gestation in pregnant women with chronic 
hypertension.  
 
Comparison A: SPE vs no SPE. Comparison B: SGA10 vs no SGA10. Comparison C: women of 
Black ethnicity vs women of non-Black ethnicity. The limits of the axes represent the maximum 
and minimum value within the dataset for each parameter. 
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Figure 4 Central aortic blood pressure across gestation in pregnant women with chronic 
hypertension 
Comparison A: SPE vs no SPE. Comparison B: SGA10 vs no SGA10. Comparison C: women of 
Black ethnicity vs women of non-Black ethnicity. The limits of the axes represent the maximum 
and minimum value within the dataset for each parameter. 
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Figure 5 Pulse wave velocity across gestation in pregnant women with chronic hypertension 
Comparison A: SPE vs no SPE. Comparison B: SGA10 vs no SGA10. Comparison C: women of 
Black ethnicity vs women of non-Black ethnicity. The limits of the axes represent the maximum 
and minimum value within the dataset for each parameter. 
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Figure 6 Augmentation index across gestation in pregnant women with chronic hypertension 
Comparison A: SPE vs no SPE. Comparison B: SGA10 vs no SGA10. Comparison C: women of 
Black ethnicity vs women of non-Black ethnicity. The limits of the axes represent the maximum 
and minimum value within the dataset for each parameter. 
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Figure 7 Augmentation index adjusted to a heart rate of 75 beats per minute across 
gestation in pregnant women with chronic hypertension 
Comparison A: SPE vs no SPE. Comparison B: SGA10 vs no SGA10. Comparison C: women of 
Black ethnicity vs women of non-Black ethnicity. The limits of the axes represent the maximum 
and minimum value within the dataset for each parameter. 
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Figure 8 Clinical systolic blood pressure across gestation in pregnant women with chronic 
hypertension.  
Comparison A: superimposed pre-eclampsia (SPE) versus no SPE. Comparison B: Women giving 
birth to infants <10
th
 birthweight centile. Comparison C: women of Black ethnicity versus non-
Black ethnicity. 
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Figure 9 Clinical diastolic blood pressure across gestation in pregnant women with chronic 
hypertension.  
Comparison A: superimposed pre-eclampsia (SPE) versus no SPE. Comparison B: Women giving 
birth to infants <10
th
birthweight centile. Comparison C: women of Black ethnicity versus non-
Black ethnicity. 
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TABLES: 
Table 1 Baseline demographics for the cohort 
Characteristic All CHT
n=97 
SPE
n=17 
CHT no SPE
n=80 
Black 
ethnicity 
n=55 
Non-Black 
ethnicity 
n=42 
Maternal age at study entry, 
years 
mean (SD) 
35 (6) 34 (6) 35 (5) 35 (5) 35 (6) 
Body mass index, Kg/m2 
mean (SD) 
31 (5.7) 31 (4.6) 30 (6.0) 32* (5.6) 29 (6.5) 
Nulliparity 
number (%) 
15 (15%) 4 (24%) 11 (14%) 2* (3.6%) 13 (31%) 
Smoker 
number (%) 
1 (1.0%) 0 1 (1.3%) 0 (0%) 1 (2.4%) 
Booking blood pressure, mmHg 
median (IQR) 
     
Systolic 
136
(126 to 142) 
138
(130 to 142) 
136
(125 to 143) 
140* 
(128 to 148) 
134
(125 to 140) 
Diastolic 
88
(80 to 92) 
84
(80 to 89) 
88
(80 to 92) 
88 
(80 to 92) 
84
(80 to 90) 
Centre 
number (%) 
     
Guy’s and St Thomas’ NHS 
Foundation Trust 
54 (56%) 6 (35%) 48 (60%) 35 (64%) 19 (45%) 
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Central Manchester University 
Hospitals NHS Foundation Trust 
32 (33%) 9 (53%) 23 (29%) 14 (25%) 18 (43%) 
St George’s University Hospitals 
NHS Foundation Trust 
11 (11%) 2 (12%) 9 (11%) 6 (11%) 5 (12%) 
Randomised to antihypertensive 
treatment 
number (%) 
87 (90%) 16 (94%) 71 (89%) 50 (91%) 37 (88%) 
Labetalol 45 (47%) 6 (35%) 39 (49%) 26 (47%) 19 (45%)
Nifedipine 42 (43%) 10 (59%) 32 (40%) 24 (44%) 18 (43%)
CHT= chronic hypertension, SPE=superimposed pre-eclampsia, SD= standard deviation, IQR= 
interquartile range 
*denotes characteristics that are significantly different between the compared subgroups 
(p=<0.05) 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Table 2 Maternal outcomes of the cohort 
Outcome All CHT
n=97 
SPE
n=17 
CHT no 
SPE 
n=80 
Black 
ethnicity 
n=55 
Non-Black 
ethnicity 
n=42 
Highest blood pressure per 
woman, mmHg 
median (IQR) 
     
Systolic 
162
(151 to 
174) 
180*
(166 to 
189) 
160 
(150 to 
169) 
167 
(153 to 175) 
158 
(150 to 171) 
Diastolic 
98 
(91 to 106) 
107*
(98 to 116) 
97 
(90 to 103) 
100  
(92 to 107) 
96
(90 to 104) 
Superimposed pre-eclampsia 
number (%) 
17 (18%) 17 (100%) 0 (0%) 7 (13%) 10 (24%) 
Mode of delivery 
number (%) 
     
Spontaneous vaginal delivery 31 (32%) 2 (12%) 29 (36%) 16 (29%) 15 (36%)
Assisted vaginal delivery 5 (5.2%) 2 (12%) 3 (3.8%) 4 (7.3%) 1 (2.4%)
Elective Caesarean section 17 (18%) 0 (0%) 17 (21%) 9 (16%) 8 (19%)
Emergency Caesarean section 44 (45%) 13* (76%) 31 (39%) 26 (47%) 18 (43%)
Gestation at delivery, weeks 
median (IQR) 
38
(37 to 
39.3) 
33*
(30.3 to 
36.4) 
39
(37.8 to 
39.3) 
38 
(37.2 to 39.3) 
38 
(36.4 to 39.2) 
Pre-term birth <37 weeks 23 (24%) 13* (76%) 10 (13%) 11 (20%) 12 (29%)
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number (%) 
Perinatal outcome 
number (%) 
     
Livebirth 94 (97%) 17 (100%) 77 (96%) 54 (98%) 40 (95%)
Stillbirth 3 (3.1%) 0 (0%) 3 (3.8%) 1 (1.8%) 2 (4.8%)
CHT= chronic hypertension, SPE=superimposed pre-eclampsia, IQR= interquartile range 
*denotes outcomes that are significantly different between the compared groups 
**Severe hypertension= systolic blood pressure ≥160 mmHg and/or diastolic blood pressure 
≥110 mmHg 
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Table 3 Neonatal outcomes for the live births within the cohort 
Outcome All CHT
n=94 
SPE
n=17 
CHT no SPE
n=77 
Black ethnicity 
n=54 
Non-Black 
ethnicity 
n=40 
Birthweight, g 
Median (IQR) 
2940
(2580 to 3260)
1560*
(1040 to 2510)
3030 
(2790 to 3460)
2980  
(2520 to 3190) 
2930 
(2650 to 3530)
Birthweight <10th 
centile (SGA10) 
number (%) 
29 (30%) 12* (71%) 17 (22%) 18 (33%) 11 (28%) 
Birthweight <3rd centile 
number (%) 
14 (14%) 10* (59%) 4 (5.2%) 9 (17%) 5 (13%) 
Neonatal unit admission 
number (%) 
21 (22%) 13* (76%) 8 (10%) 10 (19%) 11 (28%) 
 
CHT= chronic hypertension, SPE=superimposed pre-eclampsia, IQR= interquartile range 
*denotes outcomes that are significantly different between the compared groups 
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Table 4 Mean vascular function parameters and adjusted mean differences across gestation 
in women who did and did not develop superimposed pre-eclampsia 
Parameter SPE
n=17 
mean (SD) 
CHT no SPE
n=80 
mean (SD) 
Adjusted mean 
difference 
(95% confidence 
interval) 
Significance
(P value) 
Brachial SBP (mmHg)  148 (17) 139 (15) 10 (4 to 16) 0.002      
Brachial DBP (mmHg) 87 (10) 82 (10) 5 (1 to 9) 0.01  
CAP (mmHg) 139 (22) 128 (16) 12 (5 to 20) 0.001 
PWV (m/s) 9.0 (1.7) 8.6 (1.4) 0.6 (-0.2 to 1.3) 0.12      
AIX (%) 21 (16) 17 (13) 4 (-1 to 9) 0.11     
AIX-75 (%) 29 (13) 22 (12) 6 (1 to 11) 0.01      
Mean difference adjusted for gestation. SD= standard deviation, SPE= superimposed pre-
eclampsia, CHT= chronic hypertensive, SBP= systolic blood pressure, DBP= diastolic blood 
pressure, CAP= central aortic pressure, PWV= pulse wave velocity, AIX= augmentation index, 
AIX-75= augmentation index adjusted for a heart rate of 75 beats per minute 
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Table 5 Mean vascular function parameters across and adjusted mean differences gestation 
in women who gave birth to a small for gestational age infant (<10th birthweight centile) 
Parameter SGA10
n=29 
mean (SD) 
CHT no SGA10
n=68 
mean (SD) 
Adjusted mean 
difference 
(95% confidence 
interval) 
Significance
(P value) 
Brachial SBP (mmHg)  146 (18) 138 (13) 9 (4 to 14) 0.001      
Brachial DBP (mmHg) 86 (13) 82 (9) 4 (1 to 8) 0.01     
CAP (mmHg) 137 (22) 127 (15) 11 (5 to 18) <0.0001 
PWV (m/s) 9.1 (1.7) 8.5 (1.3) 0.7 (0.1 to 1.4) 0.02      
AIX (%) 19 (15) 17 (13) 3 (-2 to 7) 0.25     
AIX-75 (%) 26 (13) 22 (12) 4 (0 to 8) 0.05     
Mean difference adjusted for gestation. SD= standard deviation, SGA10= birthweight <10th 
centile, CHT= chronic hypertensive, SBP= systolic blood pressure, DBP= diastolic blood pressure, 
CAP= central aortic pressure, PWV= pulse wave velocity, AIX= augmentation index, AIX-75= 
augmentation index adjusted for a heart rate of 75 beats per minute 
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Table 6 Mean vascular function parameters and adjusted mean differences across gestation 
in women of Black and non-Black ethnicity 
Parameter Black
n=55 
mean (SD) 
Non-Black
n=42 
mean (SD) 
Adjusted mean 
difference 
(95% confidence 
interval) 
Significance
(P value) 
Brachial SBP (mmHg)  142 (17) 139 (13) 4 (-1 to 8) 0.17    
Brachial DBP (mmHg) 84 (11) 82 (9) 2 (-1 to 5) 0.18    
CAP (mmHg) 132 (19) 128 (17) 5 (-1 to 11) 0.12 
PWV (m/s) 8.7 (1.5) 8.6 (1.5) 0.3 (-0.3 to 0.9) 0.34 
AIX (%) 18 (13) 17 (15) 2 (-2 to 6) 0.45    
AIX-75 (%) 23 (12) 23 (14) 1 (-3 to 5) 0.52  
Mean difference adjusted for gestation. SD= standard deviation, CHT= chronic hypertensive, 
SBP= systolic blood pressure, DBP= diastolic blood pressure, CAP= central aortic pressure, PWV= 
pulse wave velocity, AIX= augmentation index, AIX-75= augmentation index adjusted for a 
heart rate of 75 beats per minute 
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